in this issue
People & Business :: Companies
Pfizer Gets Approval from European Commission for $68-Billion Wyeth Acquisition
2:10 AM MDT | July 20, 2009 | Deepti Ramesh
Pfizer says that the European Commission, under the European Union Merger Regulation, has approved Pfizer’s previously announced acquisition of Wyeth for a total of $68 billion. Pfizer agreed to acquire Wyeth in January 2009 in a deal that the companies say will create one of the most diversified health care firms worldwide. The merged company would offer a broad product portfolio including 17 products with more than $1 billion/year each in revenue. No drug is expected to account for more than 10% of the combined entity’s revenue in...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee